GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Afatinib | qRT-PCR followed by SFA | NA | 0.2 | 0.0604 | 29532558
|
ABCB1 | 40 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.0604 | 17510412
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SP assay followed by invasion assay and RT-PCR | NA | 0.2 | 0.1739 | 17510412
|
KLF4 | 6348 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.0891 | 33670440
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5461 | 33670440
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.6448 | 33670440
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | qRT-PCR followed by SFA | NA | 0.2 | 0.5695 | 33670440
|
ALDH1A1 | 402 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.12 | 0.684 | 25881239
|
EPCAM | 11529 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.12 | 0.211 | 25881239
|
ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.0583 | 33670440
|
ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Curcumin+Cisplatin | FACs followed by SFA | NA | 0.12 | 0.0583 | 26531053
|
ALCAM | 400 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.0583 | 29868483
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by ALDEFLUOR assay | NA | 0.12 | 0.684 | 31466290
|
EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.211 | 33670440
|
EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | Curcumin+Cisplatin | FACs followed by SFA | NA | 0.12 | 0.211 | 26531053
|
EPCAM | 11529 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.211 | 29868483
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs | NA | 0.12 | 0.7582 | 34827096
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | FACs followed by SFA | NA | 0.12 | 0.7582 | 31466290
|
AASS | 17366 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ABCA12 | 14637 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
ABLIM1 | 78 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ABR | 81 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ACAT2 | 94 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ACER3 | 16066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ACO1 | 117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ACOT7 | 24157 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ACOT9 | 17152 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ACP6 | 29609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ACSBG1 | 29567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ACSL1 | 3569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
ACSL4 | 3571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ACSS3 | 24723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ACTN1 | 163 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ACTR1A | 167 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ACTR3B | 17256 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ADAM28 | 206 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ADAMTS1 | 217 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ADAMTS3 | 219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ADAMTS6 | 222 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ADGRF1 | 18990 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ADGRL2 | 18582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ADGRV1 | 17416 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ADH5 | 253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ADH7 | 256 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ADORA2B | 264 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
AFAP1-AS1 | 28141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AFAP1L2 | 25901 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
AGR2 | 328 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
AJUBA | 20250 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
AK4 | 363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
AKR1C1 | 384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0085 | 25881239
|
AKR1C2 | 385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
AKR1E2 | 23437 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AKT3 | 393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ALDH1A3 | 409 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0201 | 25881239
|
AMOTL1 | 17811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
AMY1A | 474 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY1A | 474 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY1B | 475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY1B | 475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY1C | 476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY1C | 476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY2A | 477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY2A | 477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
AMY2B | 478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ANK2 | 493 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ANKRD22 | 28321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ANKRD31 | 26853 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ANO1 | 21625 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ANO4 | 23837 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ANPEP | 500 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
ANTXR2 | 21732 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
ANXA6 | 544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
ANXA8 | 546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ANXA8L1 | 23334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ANXA9 | 547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
AP2M1 | 564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
APBB2 | 582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
APOBEC3C | 17353 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
APOD | 612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
AREG | 651 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
AREG | 651 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
ARFGEF3 | 21213 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARGLU1 | 25482 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARHGAP1 | 673 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ARHGAP10 | 26099 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARHGAP23 | 29293 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARHGAP29 | 30207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ARHGAP32 | 17399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ARHGAP42 | 26545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARHGAP42 | 26545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARHGDIB | 679 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
ARHGEF10 | 14103 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ARHGEF38 | 25968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARHGEF9 | 14561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARID3B | 14350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARID4A | 9885 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARL17A | 24096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARL17B | 32387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ARL4C | 698 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ARL4D | 656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARNTL2 | 18984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARPP19 | 16967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARPP19 | 16967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARSJ | 26286 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ARSK | 25239 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ATP10D | 13549 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ATP13A3 | 24113 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ATP1B3 | 806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ATP6V0D1 | 13724 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ATP6V1D | 13527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ATP7A | 869 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ATP7B | 870 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ATP8A1 | 13531 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ATP9A | 13540 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
B3GNT5 | 15684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
B4GALT6 | 929 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BAG3 | 939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
BCAR3 | 973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BCAS1 | 974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
BCAS2 | 975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
BCAT1 | 976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
BCL2A1 | 991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BCL7A | 1004 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BCL9 | 1008 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
BFAR | 17613 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
BHLHE41 | 16617 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
BLOC1S2 | 20984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BMP6 | 1073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
BNC1 | 1081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
BNIP3 | 1084 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
BPIFB1 | 16108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
BPNT1 | 1096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
BTBD10 | 21445 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
C11ORF24 | 1174 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
C11ORF54 | 30204 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
C21ORF91 | 16459 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
C2CD5 | 29062 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
C2ORF15 | 28436 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
C3 | 1318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
CA2 | 1373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CABLES1 | 25097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CABYR | 15569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CACNA1D | 1391 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CACNA2D1 | 1399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
CACNB4 | 1404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CADPS2 | 16018 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CAMK1D | 19341 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CAP1 | 20040 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CAPRIN2 | 21259 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CASD1 | 16014 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CASP4 | 1505 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CAV1 | 1527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
CAV2 | 1528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
CAVIN3 | 9400 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CCBE1 | 29426 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CCDC125 | 28924 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CCDC125 | 28924 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CCDC169 | 34361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CCDC50 | 18111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CCL20 | 10619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
CCND2 | 1583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CCSER1 | 29349 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CD109 | 21685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
CD274 | 17635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CD302 | 30843 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CD44 | 1681 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 1 | 25881239
|
CD47 | 1682 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CD59 | 1689 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CD72 | 1696 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CD99 | 7082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CD99 | 7082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CDC20 | 1723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CDC25A | 1725 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CDC42EP3 | 16943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CDC6 | 1744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CDCP1 | 24357 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CDH11 | 1750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
CDH13 | 1753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CDH2 | 1759 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0085 | 25881239
|
CDH26 | 15902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CDH3 | 1762 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CDK17 | 8750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CDK6 | 1777 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CDKN1A | 1784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
CDKN1B | 1785 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CDKN2B-AS1 | 34341 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CDRT1 | 14379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CEACAM5 | 1817 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CEACAM6 | 1818 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CENPW | 21488 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CEP170 | 28920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CFAP20DC | 24763 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CFAP251 | 28506 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CGN | 17429 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CHD6 | 19057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CHD7 | 20626 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CHRNB1 | 1961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CHST11 | 17422 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CITED2 | 1987 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CKAP2L | 26877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CLCA2 | 2016 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CLCC1 | 29675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CLDN10 | 2033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CLDN10 | 2033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CLDN11 | 8514 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CLDN4 | 2046 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CLDND1 | 1322 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CLEC2D | 14351 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CLGN | 2060 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CLMP | 24039 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CLSPN | 19715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CLSTN1 | 17447 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CLTB | 2091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CMBL | 25090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CNN2 | 2156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CNN3 | 2157 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CNTN3 | 2173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
COBL | 22199 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
COL12A1 | 2188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
COL17A1 | 2194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
CORO1C | 2254 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CORO2A | 2255 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
COTL1 | 18304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CP | 2295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CPA4 | 15740 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
CPE | 2303 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CPM | 2311 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
CPOX | 2321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CPOX | 2321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CRACR2A | 28657 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CRACR2A | 28657 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CREB3L1 | 18856 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
CREB5 | 16844 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CREBZF | 24905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CRSP8P | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CRYBG1 | 356 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CSAG2 | 16847 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CSAG3 | 26237 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CSRP1 | 2469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CSTA | 2481 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CTDSPL | 37294 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CTNNAL1 | 2512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CTNNB1 | 2514 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0647 | 25881239
|
CTPS1 | 2519 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CTSB | 2527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
CTSC | 2528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CTTNBP2NL | 25330 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
CXCL1 | 4602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
CXCL17 | 19232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CXCL2 | 4603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
CXCL5 | 10642 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
CXXC5 | 26943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
CYLD | 2584 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
CYP1B1 | 2597 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
CYP2C19 | 2621 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
CYP2C8 | 2622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
CYR61 | 2654 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
DAB2 | 2662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
DAPP1 | 16500 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
DCBLD2 | 24627 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DCLK1 | 2700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0159 | 25881239
|
DCLRE1B | 17641 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DDAH1 | 2715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DDHD1 | 19714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DDX3Y | 2699 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
DDX58 | 19102 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DENND11 | 29472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DENND1B | 28404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DENND1B | 28404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DENND2C | 24748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DENND2C | 24748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DEPTOR | 22953 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DFNA5 | 2810 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DGKA | 2849 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
DHRS1 | 16445 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DHRS9 | 16888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
DIAPH2 | 2877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DIPK1A | 32213 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DKK1 | 2891 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
DKK3 | 2893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
DLG3 | 2902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
DLG5 | 2904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
DMKN | 25063 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
DNAH14 | 2945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
DNMBP | 30373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DOP1B | 1291 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
DPP10 | 20823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DSC3 | 3037 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DSE | 21144 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DSG3 | 3050 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
DTNA | 3057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
DUSP11 | 3066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
DUSP6 | 3072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
DUSP7 | 3073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
DUXAP9 | 32188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DUXAP9 | 32188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
DYNC1LI1 | 18745 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DZIP1 | 20908 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
DZIP1 | 20908 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
E2F7 | 23820 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EBP | 3133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
EBPL | 18061 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
EDEM1 | 18967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EDNRA | 3179 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EEA1 | 3185 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EFEMP1 | 3218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
EFNB1 | 3226 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EGF | 3229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
EGFR | 3236 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
EGR2 | 3239 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
EHD2 | 3243 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EHD4 | 3245 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EID3 | 32961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
EIF4E3 | 31837 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ELAPOR1 | 29618 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ELAPOR2 | 21945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ELF3 | 3318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
ELF5 | 3320 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ELK3 | 3325 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ELL2 | 17064 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ELOF1 | 28691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ELOVL1 | 14418 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ELP1 | 5959 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EMB | 30465 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EMC1 | 28957 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EMP2 | 3334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ENPEP | 3355 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ENPP1 | 3356 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ENTPD3 | 3365 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ENTPD7 | 19745 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EOGT | 28526 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EPB41 | 3377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
EPHX1 | 3401 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
EPS8 | 3420 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ERAP1 | 18173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ERAP2 | 29499 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ERBB3 | 3431 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
ERC1 | 17072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ERC2 | 31922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ERCC6 | 3438 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EREG | 3443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ERLIN1 | 16947 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ESYT1 | 29534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ETNK2 | 25575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ETNPPL | 14404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ETS1 | 3488 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ETV1 | 3490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
EWSR1 | 3508 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
EXOC2 | 24968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EXOC4 | 30389 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
EXOC6B | 17085 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EXPH5 | 30578 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
EXT1 | 3512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
EXT2 | 3513 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EXTL3 | 3518 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
EZH2 | 3527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 25881239
|
F3 | 3541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
F5 | 3542 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
F8A1 | 3547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
F8A2 | 31849 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
F8A3 | 31850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAAH2 | 26440 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
FABP6 | 3561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FADS2 | 3575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
FAM122B | 30490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAM126A | 24587 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FAM184A | 20991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAM185A | 22412 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAM214A | 25609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FAM36A | 26970 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAM83B | 21357 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FAR2 | 25531 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FAS | 11920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FAT1 | 3595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FAT2 | 3596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FAT4 | 23109 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FAXDC2 | 1334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FBN2 | 3604 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FBXL2 | 13598 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FBXW10 | 1211 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FER | 3655 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FER1L6 | 28065 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FERMT1 | 15889 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FEZ1 | 3659 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FGF11 | 3667 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FGF5 | 3683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FGFBP1 | 19695 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FGFR2 | 3689 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FHIT | 3701 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FHL1 | 3702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FHOD3 | 26178 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FJX1 | 17166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FKBP15 | 23397 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FKBP5 | 3721 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FLI1 | 3749 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FLII | 3750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FLNB | 3755 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FLRT2 | 3761 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FMO5 | 3773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FOCAD | 23377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FOS | 3796 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
FOXA1 | 5021 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
FOXP1 | 3823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FOXP2 | 13875 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FRK | 3955 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
FRMD4B | 24886 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
FRMD6 | 19839 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
FRMPD3 | 29382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
FRY | 20367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FSCN1 | 11148 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
FSIP2 | 21675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FSIP2 | 21675 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FST | 3971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FSTL1 | 3972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
FTL | 3999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
FTSJ1 | 13254 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FUT11 | 19233 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FXYD5 | 4029 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
FZD5 | 4043 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
FZD6 | 4044 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
G0S2 | 30229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
G6PD | 4057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
GAB2 | 14458 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
GABPB2 | 28441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GABRA3 | 4077 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GALNT12 | 19877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
GALNT13 | 23242 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GALNT14 | 22946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GAREM1 | 26136 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GBF1 | 4181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GBP1 | 4182 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GBP3 | 4184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GBP3 | 4184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GBP6 | 25395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GCA | 15990 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GCNT4 | 17973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GDPD3 | 28638 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GINM1 | 21074 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GIT2 | 4273 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GJB2 | 4284 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
GJB5 | 4287 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GLB1 | 4298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GLB1L2 | 25129 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GLCCI1 | 18713 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GLI3 | 4319 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GLIPR1 | 17001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GM2A | 4367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GNA15 | 4383 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GNAI2 | 4385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GNAI3 | 4387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GNB4 | 20731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GNG4 | 4407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GNPTAB | 29670 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GPAM | 24865 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GPD1L | 28956 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GPR141 | 19997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
GPR18 | 4472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GPR87 | 4538 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
GPSM2 | 29501 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GPX3 | 4555 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
GRB7 | 4567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GRHL1 | 17923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GRK5 | 4544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GSDMC | 7151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
GSE1 | 28979 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GSR | 4623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GSTA1 | 4626 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GSTM1 | 4632 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GTF3A | 4662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUCY1A1 | 4685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUCY1B2 | 4686 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUSBP1 | 13670 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUSBP2 | 18792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUSBP3 | 37301 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GUSBP3 | 37301 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
GYS1 | 4706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
H1-0 | 4714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
H1-1 | 4715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
H2BC12 | 13954 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
H2BC18 | 24700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H2BC18 | 24700 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H2BC21 | 4760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
H2BC21 | 4760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
H2BP1 | 20560 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H2BP1 | 20560 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H3-3A | 4764 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H4C14 | 4794 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
H4C15 | 29607 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
H4C8 | 4788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
HACD4 | 20920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HARS1 | 4816 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HBEGF | 3059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HCFC2 | 24972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HCLS1 | 4844 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HEG1 | 29227 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
HEPHL1 | 30477 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
HERC3 | 4876 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
HERC6 | 26072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
HLA-A | 4931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
HLA-J | 4967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HMCES | 24446 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HMGA2 | 5009 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
HMGN5 | 8013 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
HMOX2 | 5014 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
HNF4G | 5026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
HNMT | 5028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
HNRNPU | 5048 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
HOMER1 | 17512 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
HOOK1 | 19884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
HOXB2 | 5113 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
HPGD | 5154 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
HTRA1 | 9476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ICA1 | 5343 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
IDH3A | 5384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IDS | 5389 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IER3 | 5392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IFFO2 | 27006 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IFI16 | 5395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IFI44 | 16938 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IFITM3 | 5414 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IFNGR1 | 5439 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IFT57 | 17367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IGF2 | 5466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
IGF2BP2 | 28867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IGFBP7 | 5476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IGSF3 | 5950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IKBIP | 26430 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
IKZF2 | 13177 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
IKZF3 | 13178 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
IL16 | 5980 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IL1A | 5991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
IL1B | 5992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
IL1RAP | 5995 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IL20RB | 6004 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IL31RA | 18969 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IL4R | 6015 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IL7R | 6024 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IL8 | 6025 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0159 | 25881239
|
ILK | 6040 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
INHBA | 6066 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
INPP5D | 6079 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
INPP5F | 17054 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
INS-IGF2 | 33527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IPO11 | 20628 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IQCA1 | 26195 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
IQGAP1 | 6110 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
IQGAP2 | 6111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
IRAK3 | 17020 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
IRF6 | 6121 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
IRS1 | 6125 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ISL1 | 6132 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ITGA2 | 6137 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0106 | 25881239
|
ITGA3 | 6139 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ITGA5 | 6141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ITGA6 | 6142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0265 | 25881239
|
ITGAV | 6150 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
ITGB4 | 6158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
ITGB6 | 6161 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
ITGB8 | 6163 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
ITGBL1 | 6164 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ITPR2 | 6181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
JAG1 | 6188 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0117 | 25881239
|
JARID2 | 6196 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
JPX | 37191 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KATNAL1 | 28361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KCNG3 | 18306 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KCNJ15 | 6261 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
KCNK2 | 6277 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KCNMA1 | 6284 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
KCNRG | 18893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KCNS3 | 6302 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KDELC2 | 28496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KDR | 6307 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KIAA0040 | 28950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
KIAA0930 | 1314 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIAA1217 | 25428 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIAA1549 | 22219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KIAA1614 | 29327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIAA1958 | 23427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KIF13A | 14566 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
KIF13B | 14405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KIF20B | 7212 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIF23 | 6392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIF2A | 6318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIF3A | 6319 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KIRREL1 | 15734 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
KLF12 | 6346 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KLF6 | 2235 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
KLF7 | 6350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
KLHDC2 | 20231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KLHL23 | 27506 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
KLRF1 | 13342 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
KPNA6 | 6399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KRR1 | 5176 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
KRT14 | 6416 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
KRT17 | 6427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
KRT4 | 6441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
KRT5 | 6442 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 25881239
|
KRT6A | 6443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
KRT6A | 6443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
KRT6B | 6444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
KRT6B | 6444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
KRT6C | 20406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
LAMA3 | 6483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
LAMB3 | 6490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
LAMC2 | 6493 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
LAPTM4B | 13646 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LAPTM5 | 29612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LCN2 | 6526 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
LCP1 | 6528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
LDLR | 6547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LEF1 | 6551 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
LGALS1 | 6561 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
LHFP | 6586 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LIFR | 6597 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LIMA1 | 24636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
LIMCH1 | 29191 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
LINC01006 | 48971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LIPG | 6623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LIX1L | 28715 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LLPH | 28229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LMO7 | 6646 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LNPEP | 6656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LOC344967 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LOC728392 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LONRF3 | 21152 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LOXL2 | 6666 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
LPAR1 | 3166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
LPAR3 | 14298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LPCAT2 | 26032 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LPXN | 14061 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LRRC37A2 | 32404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LRRC37A3 | 32427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LRRC37A4P | 25479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LRRC37A4P | 25479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
LRRC8A | 19027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LRRC8C | 25075 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
LRRCC1 | 29373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LTBP1 | 6714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LUZP1 | 14985 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
LY75 | 6729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LY75 | 6729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
LYST | 1968 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MACsC1 | 30215 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
MACsO1 | 25572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MACsROD2 | 16126 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MAGI1 | 946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MAL2 | 13634 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
MAOA | 6833 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MAP4K4 | 6866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MAP4K5 | 6867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MAPK10 | 6872 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
MAPK6 | 6879 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MAPKAPK3 | 6888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MBIP | 20427 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MBNL2 | 16746 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MBOAT2 | 25193 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MBTD1 | 19866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MCAM | 6934 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
MCC | 6935 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MCCC1 | 6936 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MCL1 | 6943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MCTP1 | 26183 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MDGA2 | 19835 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ME1 | 6983 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
MED27 | 2377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MEF2C | 6996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MERTK | 7027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MEST | 7028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MFAP5 | 29673 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MFN2 | 16877 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MFSD14B | 23376 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MFSD2A | 25897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MGAT4A | 7047 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
MGC70870 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MICAL2 | 24693 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MICALCL | 24693 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MIEN1 | 28230 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MINDY1 | 25648 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MIPOL1 | 21460 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MIR198 | 31570 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MIR205 | 31583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MITF | 7105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MMP1 | 7155 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MMP10 | 7156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MMP14 | 7160 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MMP2 | 7166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MOB3B | 23825 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MORC3 | 23572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MPP1 | 7219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MPZL2 | 3496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
MRPL30 | 14036 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MSANTD3-TMEFF1 | 38838 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MSN | 7373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
MT1DP | 7396 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MT1E | 7397 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MT1G | 7399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MT1L | 7404 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MT1P3 | 16120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MT1X | 7405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MT2A | 7406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MTAP | 7413 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
MTRF1 | 7469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MTSS1 | 20443 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
MUC5B | 7516 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
MX2 | 7533 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MXI1 | 7534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
MYB | 7545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
MYBL1 | 7547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MYH11 | 7569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MYO1B | 7596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
MYO5A | 7602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
MYO5B | 7603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
MYOF | 3656 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
NAALADL2 | 23219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NABP1 | 26232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
NAPEPLD | 21683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NAV1 | 15989 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NAV3 | 15998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
NBEA | 7648 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NBR2 | 20691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NCEH1 | 29260 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
NDE1 | 17619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NDRG1 | 7679 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
NDST1 | 7680 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NDUFA3 | 7686 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NEB | 7720 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NEBL | 16932 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NECAP2 | 25528 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NECTIN1 | 9706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NECTIN3 | 17664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NEDD1 | 7723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NEDD4 | 7727 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NEK1 | 7744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NEK5 | 7748 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
NEU1 | 7758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NEU1 | 7758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NEXN | 29557 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NFATC2 | 7776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NFE2L1 | 7781 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NFIX | 7788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
NFKB1 | 7794 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
NFKBIZ | 29805 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NIPAL1 | 27194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NIPAL4 | 28018 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NIPSNAP3A | 23619 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NLRP1 | 14374 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NPC1 | 7897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
NPNT | 27405 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
NPR3 | 7945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NPR3 | 7945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NRG1 | 7997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NRG1 | 7997 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NRN1 | 17972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NRP2 | 8005 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
NSUN7 | 25857 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NT5DC3 | 30826 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NTAN1 | 29909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NTM | 17941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NUDT11 | 18011 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
NUP210 | 30052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
NXT2 | 18151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
OAT | 8091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
OCIAD2 | 28685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
OCLN | 8104 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ODR4 | 24299 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
OGT | 8127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
OPHN1 | 8148 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
OPTN | 17142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
OR13H1 | 17142 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
OR7E14P | 8234 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ORMDL2 | 8385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
OSBPL1A | 16395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
OSBPL8 | 16398 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
OXCT1 | 8527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
OXSR1 | 8508 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
P4HA1 | 8546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
P4HA2 | 8547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PAK1 | 8590 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PAK2 | 8591 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PAK3 | 8592 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PALMD | 15846 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PANX1 | 8599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PARD3B | 16051 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PARVA | 24536 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PAX9 | 8623 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PBOV1 | 21079 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PBX3 | 8634 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PCDH20 | 14257 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
PCDHB2 | 8687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PCDHB5 | 8690 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PCID2 | 25653 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PCMT1 | 8728 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PCMTD2 | 15882 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PCYT1A | 8754 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PDCD1LG2 | 18731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PDE3B | 8779 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PDE4DIP | 15580 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PDE5A | 8784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
PDGFA | 8799 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PDGFC | 8801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PDLIM1 | 2067 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PDPN | 29602 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PDXDC1 | 28995 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PECR | 18281 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PELI2 | 8828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PEX1 | 8850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PFDN1 | 8866 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PGAM1 | 8888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PGAM4 | 21731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PGAP3 | 23719 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PGBD3 | 19400 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PGM3 | 8907 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PHLDA1 | 8933 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PHLDB2 | 29573 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PHOSPHO2 | 28316 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PI4K2A | 30031 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PIK3C2B | 8972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
PINK1 | 14581 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PIP4K2C | 23786 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PIP4P2 | 25452 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PKP1 | 9023 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PLA2G10 | 9029 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PLAT | 9051 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
PLAU | 9052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PLAUR | 9053 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0085 | 25881239
|
PLCB1 | 15917 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PLEK2 | 19238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PLEKHA1 | 14335 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PLEKHA6 | 17053 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PLEKHA7 | 27049 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PLEKHG1 | 20884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
PLOD1 | 9081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PLOD2 | 9082 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
PLXNA1 | 9099 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PLXNA2 | 9100 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PODXL | 9171 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
POLH | 9181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
POLR2A | 9187 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
POLR3A | 30074 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PORCN | 17652 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
POTEB | 33734 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
POTEE | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
POTEE | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
POTEF | 33895 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
POTEF | 33905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
POTEG | 33896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
POTEG | 33896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
POTEH | 133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
POTEM | 37096 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
POU6F2 | 21694 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PPARD | 9235 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PPFIBP2 | 9250 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
PPP1R18 | 29413 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PPP1R9A | 14946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PPP2R3A | 9307 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PPP3CB | 9315 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PPP3CC | 9316 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PPP4R1 | 9320 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PPP4R4 | 23788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PREP | 9358 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PREX2 | 22950 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PRICKLE1 | 17019 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PRKAA2 | 9377 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PRKAG1 | 9385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PRKAR2B | 9392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PRKD1 | 9407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PRKG1 | 9414 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PRSS1 | 9475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PRSS1 | 9475 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PRSS2 | 9483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PRSS3 | 9486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PRSS3P2 | 43788 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PRSS48 | 24635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PRTFDC1 | 23333 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
PRXL2C | 16881 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PSMA5 | 9534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PSMB7 | 9544 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PSMD2 | 9559 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PSTPIP2 | 9581 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PTAFR | 9582 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PTGFRN | 9601 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PTGR2 | 20149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
PTGS2 | 9605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
PTH2R | 9609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
PTHLH | 9607 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PTK2B | 9612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PTPN14 | 9647 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PTPRE | 9669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
PTPRG | 9671 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PTPRK | 9674 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
PTPRZ1 | 9685 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PTTG1IP | 13524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
PXDN | 14966 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
PYGL | 9725 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
QPCT | 9753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RAB11FIP1 | 30265 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
RAB18 | 14244 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RAB27B | 9767 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
RAB31 | 9771 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
RAB38 | 9776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RAB3B | 9778 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RAC2 | 9802 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RALGAPA2 | 16207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RAPGEF5 | 16862 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
RAPGEFL1 | 17428 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
RARB | 9865 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
RASA2 | 9872 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RASA4 | 23181 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RASEF | 26464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RASGEF1B | 24881 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RASGRP3 | 14545 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RASSF6 | 20796 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RASSF8 | 13232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
RBM47 | 30358 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RBMS2 | 9909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RBP1 | 9919 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RC3H2 | 21461 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RDH10 | 19975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
REEP3 | 23711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
REEP3 | 23711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
REPIN1 | 17922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RERG | 15980 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
REXO2 | 17851 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RFTN1 | 30278 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RGL1 | 30281 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RGS2 | 9998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RGS5 | 10001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RHOC | 669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
RHPN2 | 19974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RIC8A | 29550 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RIMS2 | 17283 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RIT1 | 10023 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RN7SK | 10037 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RNF11 | 10056 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RNF152 | 26811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RNF19B | 26886 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RNF213 | 14539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RNF213 | 14539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RNF217 | 21487 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
RNFT2 | 25905 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RNU1-1 | 10120 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RNY4P8 | 34057 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RP2 | 10274 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RPL13A | 10304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
RPP14 | 30327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RPPH1 | 19273 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
RPS4Y1 | 10425 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RRAGC | 19902 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RRAGD | 19903 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RSBN1L | 24765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
RSU1 | 10464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
RTKN2 | 19364 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
S100A14 | 18901 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
S100A16 | 20441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
S100A2 | 10492 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
S100A8 | 10498 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
S100P | 10504 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0106 | 25881239
|
SAA1 | 10513 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SACS | 10519 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SAMD12 | 31750 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SAMD9 | 1348 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SAR1A | 10534 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SATB1 | 10541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SATB2 | 21637 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SCAMP2 | 10564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SCARNA9 | 32566 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SCCPDH | 24275 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SCEL | 10573 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SCNN1A | 10599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
SCPEP1 | 29507 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SCYL2 | 19286 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SDC2 | 10659 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SEC13 | 10697 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SEC14L2 | 10699 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SEC22C | 16828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SELENON | 15999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SELENOP | 10751 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SELENOW | 10752 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SEMA3A | 10723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SEMA3E | 10727 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SEMA6D | 16770 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SEMA7A | 10741 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SERINC2 | 23231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SERPINB2 | 8584 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SERPINB5 | 8949 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
SERPINB8 | 8952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SERPINE1 | 8583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
SERPINE2 | 8951 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SERPINF1 | 8824 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SERPINH1 | 1546 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SESN1 | 21595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SESTD1 | 18379 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SFN | 10773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
SFXN1 | 16085 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SGCB | 10806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SGK1 | 10810 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
SH3BGRL | 10823 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
SH3BGRL2 | 15567 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SH3GLB1 | 10833 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SH3PXD2A | 23664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
SH3RF2 | 26299 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SHC1 | 10840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SHCBP1 | 29547 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SHMT2 | 10852 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SIDT1 | 25967 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SIKE1 | 26119 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SIRPA | 9662 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SKAP2 | 15687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SLAIN1 | 26387 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC10A7 | 23088 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC15A4 | 23090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC16A14 | 26417 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC16A2 | 10923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC1A1 | 10939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC20A1 | 10946 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC20A2 | 10947 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC25A21 | 14411 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC25A30 | 27371 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC26A2 | 10994 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC30A4 | 11015 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC30A7 | 19306 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC35D1 | 20800 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC37A2 | 20644 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC40A1 | 10909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC41A2 | 31045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC43A3 | 17466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC44A4 | 13941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC44A4 | 13941 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC44A5 | 28524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC4A7 | 11033 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLC6A11 | 11044 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLC6A6 | 11052 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SLC8A1 | 11068 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SLC9A1 | 11071 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SLCO1A2 | 10956 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SLCO3A1 | 10952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SLCO4C1 | 23612 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SLFN13 | 26481 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SLPI | 11092 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0074 | 25881239
|
SLX4IP | 16225 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SMAD9 | 6774 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SMARCD1 | 11106 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SMIM14 | 27321 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SMN1 | 11117 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SMURF2 | 16809 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SNAI2 | 11094 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0159 | 25881239
|
SNAP23 | 11131 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SNCA | 11138 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SNORA50A | 32643 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORA71A | 10232 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORD13 | 32711 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORD13P2 | 10111 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORD33 | 10160 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORD4B | 10098 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SNORD5 | 32702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SNRK | 30598 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SNTB1 | 11168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SNX10 | 14974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SOHLH2 | 26026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SORBS2 | 24098 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SORD | 11184 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SOWAHC | 26149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SP140L | 25105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXA1 | 11218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXA1 | 11218 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXA2 | 14328 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXA2 | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXC | 14331 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPANXD | 14332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPARC | 11219 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SPCS3 | 26212 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SPDYE1 | 16408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SPDYE2 | 33841 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE5 | 35464 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPDYE7P | 35466 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPIN3 | 27272 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SPP1 | 11255 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SPRR1B | 11260 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SPTLC3 | 16253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SPTSSB | 24045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SQOR | 20390 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
SREK1IP1 | 26716 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SRPX | 11309 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
SRXN1 | 16132 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
SSPN | 11322 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SSR3 | 11325 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ST6GALNAC2 | 10867 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
STARD4 | 18058 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
STARD5 | 18065 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
STAT6 | 11368 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
STC1 | 11373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
STEAP1 | 11378 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
STEAP2 | 17885 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
STEAP4 | 21923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
STK10 | 11388 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
STK17A | 11395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
STOM | 3383 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
STX2 | 3403 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
STX3 | 11438 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
STX6 | 11441 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
STXBP1 | 11444 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
STXBP5 | 19665 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SULF2 | 20392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
SURF4 | 11476 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
SVIP | 25238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SYCP2 | 11490 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
SYCP2L | 21537 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
SYDE2 | 25841 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SYT14 | 23143 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
SYTL5 | 15589 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TAF1D | 28759 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TAGLN3 | 29868 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TAOK3 | 18133 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TAS2R14 | 14920 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TBC1D2 | 18026 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TBC1D23 | 25622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TBC1D30 | 29164 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TBC1D4 | 19165 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TC2N | 19859 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TCEAL9 | 30084 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TCF7L1 | 11640 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TEC | 11719 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TENM2 | 29943 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TESK1 | 11731 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TEX15 | 11738 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TFAP2A | 11742 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TFPI2 | 11761 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
TGFA | 11765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TGFBR1 | 11772 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TGFBR2 | 11773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
THBS1 | 11785 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
THOC3 | 19072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
THOC3 | 19072 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TIGD1 | 14523 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TIMM22 | 17317 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TIMM23 | 17312 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TIMP1 | 11820 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
TIMP3 | 11822 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
TIMP3 | 11822 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
TINAGL1 | 19168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TIPARP | 23696 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TLE4 | 11840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TLR4 | 11850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TM2D2 | 24127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMC5 | 22999 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TMC7 | 23000 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMCC3 | 29199 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TMED7 | 24253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMEM14B | 21384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TMEM154 | 26489 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMEM184B | 1310 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMEM40 | 25620 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TMEM43 | 28472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TMEM45A | 25480 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
TMEM45B | 25194 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
TMEM63A | 29118 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TMEM75 | 32295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TMPRSS11D | 24059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMPRSS4 | 11878 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
TMTC3 | 26899 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TMTC4 | 25904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TNC | 5318 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TNFAIP1 | 11894 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TNFAIP3 | 11896 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 25881239
|
TNFRSF21 | 13469 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TNFSF10 | 11925 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TNFSF15 | 11931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TNIK | 30765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 25881239
|
TNIP1 | 16903 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TNS4 | 24352 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
TOX3 | 11972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TP63 | 15979 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TPD52L1 | 12006 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
TPM4 | 12013 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 25881239
|
TPRG1L | 27007 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TPST1 | 12020 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TRAF3IP2 | 1343 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TRAM2 | 16855 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
TRIM13 | 9976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TRIM2 | 15974 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TRIM24 | 11812 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TRIM29 | 17274 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0074 | 25881239
|
TRIM33 | 16290 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TSHZ2 | 13010 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TSPAN14 | 23303 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TSPAN15 | 23298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
TSPAN5 | 17753 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TSPAN7 | 11854 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
TSPAN8 | 11855 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TSPYL5 | 29367 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TTBK2 | 19141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TTLL7 | 26242 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TUBA4A | 12407 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TUBB2A | 12412 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
TUBB2B | 30829 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TUBB6 | 20776 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
TXNDC16 | 19965 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 25881239
|
TXNRD1 | 12437 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
UBASH3B | 29884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
UBE3B | 13478 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
UBL3 | 12504 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
UBN2 | 21931 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
UCP2 | 12518 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
UGCG | 12524 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
UPP1 | 12576 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
USP9Y | 12633 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
VAMP3 | 12644 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
VAV2 | 12658 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
VCL | 12665 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
VCP | 12666 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 25881239
|
VEGFC | 12682 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
VGLL1 | 20985 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
VIM | 12692 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.017 | 25881239
|
VSNL1 | 12722 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
WDFY2 | 20482 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
WDR47 | 29141 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
WFDC2 | 15939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 25881239
|
WIPF2 | 30923 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
WLS | 30238 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
WNK3 | 14543 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
WNT7A | 12786 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 25881239
|
WWTR1 | 24042 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
XBP1 | 12801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
XDH | 12805 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
YIPF1 | 25231 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZBED2 | 20710 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZBTB38 | 26636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZBTB38 | 26636 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZC3H6 | 24762 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZDBF2 | 29313 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZDHHC16 | 20714 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZDHHC3 | 18470 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ZFHX3 | 777 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ZFP28 | 17801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZFP36L1 | 1107 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ZFY | 12870 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZMYM1 | 26253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZMYM2 | 12989 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF20 | 12992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF280B | 23022 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF3 | 13089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF323 | 14097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF462 | 21684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF486 | 20807 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ZNF542P | 25393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF561 | 28684 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ZNF625 | 30571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 25881239
|
ZNF652 | 29147 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF670 | 28167 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF681 | 26457 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ZNF695 | 30954 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ZNF724 | 32460 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF767P | 21884 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|
ZNF790 | 33114 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF83 | 13158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 25881239
|
ZNF92 | 13168 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 25881239
|
ZSCAN21 | 13104 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H2170 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 25881239
|